FBTCX (Fidelity Adv Biotech;C)
Net Asset Value: 12.44
1-Day Return:
0.06 (0.48%)
YTD Return as of 4/4/13: 19.04%
Classification: Health/Biotech Objective: Health/Biotech Open to New Investors: Yes
Lipper Rating
The Lipper Leader system ranks a fund in the following categories: Total Return; Consistent Return; Preservation; Tax Efficiency; and Expenses. Funds are rated in ascending order on a numeric scale of 1 to 5, with '1' representing funds with the lowest rating, and '5' representing the highest rated funds and funds that are Lipper Leaders. Click here for more detail.
| Growth of $10,000
Total Returns (As of 4/04/2013)
More| YTD | 1Yr | 3Yr | 5Yr | 10Yr | |
| Fund | 19.04 | 36.02 | 23.33 | 15.92 | 11.66 |
| Classification | 15.53 | 23.65 | 16.03 | 12.33 | 11.20 |
| Index (S&P 500) | NA | NA | NA | NA | NA |
| % Rank in Class (1-best,100=worst) | 9 | 8 | 9 | 23 | 42 |
Fund Stats
More| Investment Objective: | Health/Biotech |
|---|---|
| Net Assets ($Mil) | NA |
| Inception Date: | 12/27/00 |
| Manager Name, Tenure | Rajiv Kaul, 2005 |
| Expense Ratio: | 2.01% |
|
Sales Charge:
Load Type:
|
Level Load 0.00% 1.00% |
Top 10 Holdings (As of 10/31/12)
More| Company Name | Symbol | % Net Assets |
|---|---|---|
| Amgen Inc Ord | AMGN | 13.04 |
| Gilead Sciences Inc Ord | GILD | 13.00 |
| Biogen Idec Inc Ord | BIIB | 6.98 |
| Regeneron Pharmaceuticals Inc Ord | REGN | 4.72 |
| Celgene Corp Ord | CELG | 4.46 |
| Onyx Pharmaceuticals Inc Ord | ONXX | 4.08 |
| Medivation Inc Ord | MDVN | 3.68 |
| Vertex Pharmaceuticals Inc Ord | VRTX | 3.62 |
| Taxable Cent Cash Fd | NA | 3.22 |
| Alexion Pharmaceuticals Inc Ord | ALXN | 2.23 |
| % of Total Holdings | 59.03 | |
